Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
39 /100
MEDIUM RISK
Score updated Oct 13, 2026

KALV — KalVista Pharmaceuticals, Inc. Dilution Risk Tracker

Track KALV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KALV — Get alerts when the score changes →

As of October 13, 2026, KalVista Pharmaceuticals, Inc. (KALV) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. KalVista Pharmaceuticals, Inc. has a market capitalization of $1.44B, 53.24M shares outstanding, 185 institutional holders tracked. Stored dilution-related fields include 3.48M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
30
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
📜 Warrant Exercise model 15%
• Warrant overhang: 6.5% of shares outstanding
🔔 Track KALV — Get forecast alerts →

Market Data

Market Cap$1.44B
Shares Outstanding53.24M
Float38.18M
Cash$213.77M
Debt$172.21M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore39/100DilutionWatch score record
Shares Outstanding53.24MVerified float table or market cache
Public Float38.18MVerified float table or market cache
Market Cap$1.44BMarket data cache
Cash Runway16.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants3.48MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.5% shares (2026Q1 vs prior)
185 institutional holders · 78.75M shares
#1 Venrock Adviser, LLC 6.47M shares
#2 Frazier Life Sciences Management, L.P. 4.96M shares
#3 SUVRETTA CAPITAL MANAGEMENT, LLC 4.77M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-05-14
xbrl XBRL CONVERTIBLE 2016-03-30
4 INSIDER TRANSACTION 2026-04-20
4 INSIDER TRANSACTION 2026-04-20
4 INSIDER TRANSACTION 2026-04-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KALV Dilution Snapshot

KalVista Pharmaceuticals, Inc. (KALV) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KALV's DilutionScore is currently 39/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 37/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202639/100MEDIUM14 days
Aug 22 – Sep 29, 202637/100MEDIUM39 days
Aug 14 – Aug 21, 202645/100MEDIUM7 days
Jul 16 – Aug 13, 202637/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KALV shares outstanding have increased 3.9% from 51.22M (Mar 2026) to 53.24M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202653.24M38.18M▼ 0.02%
May 29, 202653.24M38.19M▼ 0.07%
May 23, 202653.24M38.21M▲ 14.92%
May 19, 202653.24M33.25M▲ 0.08%
May 18, 202653.24M33.23M▲ 4.65%
May 17, 202653.24M31.75M▼ 4.71%
May 12, 202653.17M33.32M▲ 2.08%
May 10, 202653.17M32.64M▲ 0.65%
May 04, 202653.17M32.43M▲ 9.81%
Apr 24, 202651.22M29.53M▼ 0.08%
Apr 11, 202651.22M29.56M▲ 5.87%
Mar 28, 202651.22M27.92M▲ 1.13%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KALV Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KALV files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KALV — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KALV
KALV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.